Document six bug reviews and guard hemp and licensing claims

@@ -0,0 +1,76 @@
+# Bug review — 28 October 2026
+
+Six open `bug` issues were reviewed. Personal-use scores are unchanged. This review separates
+permission to grow a hemp crop, permission to manufacture controlled medicines, and patient supply.
+
+| Issue | Profile | Resolution |
+|---|---|---|
+| #241 | Pakistan | Fixed the residual “still being built” claim in medical context. Current production application categories are documented; patient supply remains unverified. |
+| #252 | Mali | Existing revocation correction retained. Open: a current national cannabis schedule and its relationship to medicine-manufacturing permissions remain unverified. |
+| #253 | Armenia | Qualified the blanket production-route denial, added the explicit licensed scientific-use exception, and distinguished restricted dronabinol from prohibited plant cannabis. Open: cannabis-specific manufacturing eligibility under the separate implementing licence rules remains unverified. |
+| #272 | Moldova | Existing `production: hemp` and `hemp: standard` correction independently verified against the current law. Added a statutory locator and review date. |
+| #273 | Bosnia and Herzegovina | Existing `production: hemp` and `hemp: strict` correction independently verified against the medicines agency and September 2026 ministry update. Updated review date. |
+| #274 | Iceland | Corrected cultivation, hemp, production and seed descriptions using the 2021 regulation; retained the 0.2% strict classification and set production to hemp. Added the 2020 exemption announcement and expanded the existing 2021 history entry. |
+
+## Sources read and limits
+
+- [Pakistan CCRA application requirements](https://www.elicense.ccra.gov.pk/pre-requisite):
+  downloaded and read with curl after the web reader timed out. Includes A-1–A-3 cultivation,
+  B-2 extraction, B-3 pharmaceutical manufacture and C-1 research. The application checklist
+  does not establish an issued licence count, a first licence date, or a pharmacy supply route.
+- [Mali Law 01-078, official gazette](https://sgg-mali.ml/JO/2002/mali-jo-2002-29.pdf):
+  Articles 3 and 7 distinguish national schedules and their amendment by decree; Article 9
+  prohibits cultivation; Article 10 prohibits Schedule I operations; Articles 12–13 provide
+  express medical authorisations for Schedules II–III. These provisions do not identify cannabis's
+  current national schedule. Searches did not locate an authoritative current schedule.
+- [OCS director's explanation, Maliweb, May 2020](https://www.maliweb.net/societe/culture-du-chanvre-industriel-au-mali-les-precisions-du-directeur-general-de-locs-2875623.html):
+  read the account of the special hemp project and 25 February 2020 revocation. The official's
+  general statement about medical hemp does not replace the missing current schedule or prove
+  a replacement authorisation. No change to Mali's already corrected production status was made.
+- [Armenia controlled-substances law](https://arlis.am/hy/acts/218654): Articles 4, 11,
+  14 and 31.1 read. Article 11 expressly permits scientific use of prohibited substances under
+  31.1 and licensed import/export for that purpose. Article 14 requires substance-specific
+  production licences and quotas. Scientific use is not itself permission to cultivate or
+  manufacture cannabis for sale.
+- [Armenia Decision 1129-N, consolidated schedules](https://arlis.am/hy/acts/222957):
+  cannabis outside the licensed hemp category is on List 1; industrial hemp and dronabinol are
+  separately on List 2. A blanket statement that every form of THC belongs on List 1 is wrong.
+  The relevant implementing manufacturing licence rules still need review before declaring a
+  cannabis-specific manufacturing route either available or universally prohibited.
+- [Moldova Law 201/2025, FAOLEX copy](https://faolex.fao.org/docs/pdf/mol240625.pdf):
+  Article 2(5) directly sets the 0.3% ceiling; Articles 12 and 14 establish ANSA oversight,
+  authorisation, permitted crop purposes and seed-variety requirements.
+- [Moldova government, 29 April 2026](https://gov.md/en/comunicate-de-presa/moldovan-government-approves-new-rules-growing-processing-marketing-industrial):
+  the indexed official text was read through search after direct requests timed out. Describes
+  flowering-time sampling, accredited laboratories, annual reporting, domestic marketing and
+  exports. No independent first-issued-licence count is claimed. The March 2025 AMDM page
+  timed out; its first-licence milestone was not newly added to history.
+- [Bosnia medicines agency, 4 August 2022](https://almbih.gov.ba/saopa-tenje-za-javnost-vezano-za-kanabis/):
+  0.2% dry-matter ceiling and fibre/seed crop purposes. Its medical prohibition is historical
+  and must be read with the later rescheduling.
+- [Bosnia Ministry of Civil Affairs, 22 September 2026](https://www.mcp.gov.ba/hr/portal/objava/odrzan-drugi-follow-up-sastanak-o-primjeni-kanabisa-u-medicinske-svrhe-1790073591914):
+  implementation remained incomplete after the December 2025 decision; no cultivation or
+  manufacturing licence is established by that prescribing-framework update.
+- [Iceland Regulation 804/2021](https://island.is/reglugerdir/nr/0804-2021): downloaded
+  and read with curl after the web reader returned 403. Articles 1–3 expressly concern seed for
+  hemp cultivation, 0.20% THC in seed and resulting products, EEA varieties and seed documentation;
+  the portal states commencement on 9 July 2021. It does not specify an indoor-growing restriction
+  or independently establish a company's permit or flower-retail legality.
+- [Iceland Medicines Agency, 14 July 2021](https://www.lyfjastofnun.is/frettir/verkefni-sem-varda-idnadarhamp-flytjast-til-matvaelastofnunar/):
+  confirms the temporary 2020 seed exemption and replacement MAST regime.
+- [Iceland Ministry of Health, 18 April 2020](https://www.stjornarradid.is/frettir/grein/2020-04-18-Raektun-idnadarhamps-verdur-heimil-i-kjolfar-reglugerdarbreytingar/):
+  indexed official announcement read through search; the history date is the announcement date,
+  not an independently established commencement date.
+- [Iceland drug act, current consolidation](https://www.althingi.is/lagas/nuna/1974065.html):
+  Articles 2 and 2b retain the general prohibition, special revocable exceptions and MAST seed
+  permit power. No claim is made that every possible medical-production exception is excluded.
+
+## Validation
+
+Profile audits for Iceland, Pakistan, Armenia, Moldova and Bosnia report no errors or warnings.
+Regression checks cover conditional hemp growing, map statuses, current Pakistan applications,
+and Armenia's scientific-use exception. All 183 tests passed, including the build's test run. Full build passed with 5,239 pages.
+SEO audit passed: 5,241 HTML files and 232,010 internal links. Rendered profiles and per-country
+JSON were checked for Iceland, Pakistan, Armenia, Moldova and Bosnia; the removed Iceland and
+Pakistan claims are absent. CSV exports carry Iceland strict/hemp, Moldova standard/hemp and
+Bosnia strict/hemp, and the new Iceland history page exists.

@@ -933,2 +933,40 @@ test('Jordan CBD permission, Czech serum and Romanian supply penalties stay dist
   assert.equal(row.prison, '10 years');
 });
+
+
+test('Iceland hemp growing is a conditional agricultural exception (#274)', () => {
+  const is = country('is');
+  assert.equal(is.context.hemp.status, 'strict');
+  assert.equal(is.context.production.status, 'hemp');
+  assert.match(is.segments.cultivation.text, /Industrial hemp.*lawful growing route/);
+  assert.match(is.context.hemp.text, /0.2% THC/);
+  assert.match(is.context.hemp.text, /EEA.*catalogue/);
+  assert.doesNotMatch(is.context.hemp.text, /bans cannabis cultivation outright|no hemp market|no THC threshold/);
+  assert.doesNotMatch(is.context.production.text, /No licensed production/);
+});
+
+test('Moldova and Bosnia classify their authorised hemp crop separately (#272–273)', () => {
+  for (const [id, status, limit] of [['md', 'standard', '0.3%'], ['ba', 'strict', '0.2%']]) {
+    const c = country(id);
+    assert.equal(c.context.production.status, 'hemp', id);
+    assert.equal(c.context.hemp.status, status, id);
+    assert.ok(c.context.hemp.text.includes(limit), id);
+    assert.equal(c.scores.access, 0, id);
+  }
+});
+
+test('Pakistan production applications are current without implying patient supply (#241)', () => {
+  const pk = country('pk');
+  assert.doesNotMatch(pk.context.medical.text, /still being built/);
+  assert.match(pk.context.medical.text, /Applicants can seek licences/);
+  assert.match(pk.context.medical.text, /Patient supply remains unverified/);
+  assert.equal(pk.scores.access, 0);
+});
+
+test('Armenian scientific exceptions survive the List No. 1 description (#253)', () => {
+  const am = country('am');
+  assert.match(am.context.production.text, /Article 11 permits licensed scientific use/);
+  assert.match(am.context.production.text, /substance-specific production licence/);
+  assert.doesNotMatch(am.context.production.text, /There is no medical or adult-use production route/);
+  assert.match(am.context.medical.text, /dronabinol/);
+});